Why The ‘Strawberry Moon' Will Be Lowest Until 2043 — And How To Photograph It
The full strawberry moon will put on a dramatic show at moonrise on Tuesday, June 10 — low, luminous, and colored orange as it climbs into the southeastern sky.
Get to an observing location that looks southeast — preferably low to the horizon — and at the specific time of moonrise where you are (during dusk), you'll see the red-orange orb rise before your eyes.
Seen from the Northern Hemisphere, the full moon will rise far to the southeast, move across the sky close to the southern horizon, and set in the southwest close to dawn. It's happening because we're in the midst of a rare two-year period known as the 'major lunar standstill" or "lunistice," when a once-in 18.6-year event will create the lowest-hanging full moon since 2006 and until 2043.
Earth's axis is tilted by 23.5 degrees with respect to the ecliptic, the path of the sun through the daytime sky, and, in effect, the plane of the solar system. That's what gives us seasons, and that's why planets are always found close to the ecliptic (hence the misused "planetary alignment" claims despite planets always being somewhat aligned with each other).
The moon's orbit crosses the ecliptic twice each month, and when those crossings align with a new or full moon, eclipses can occur — hence the shared root in the words 'ecliptic' and 'eclipse.'
While the sun's rise and set points vary throughout the year, changing by 47 degrees — and reaching the extreme points at the solstices — the moon's range is bigger, with that 5-degree tilt giving its rise and set points a 70-degree range near a major standstill, according to Griffith Observatory.
Mount Coot-tha Lookout, Brisbane
A major lunar standstill is a period when the northernmost and southernmost moonrise and moonset are furthest apart. Unlike a solstice (Latin for "sun stand still"), which lasts for one day, a major lunar standstill lasts for two years. These events are most noticeable during a full moon. Essentially, the swiveling and shifting orbit of the moon — a consequence of the sun's gravitational pull — is tilted at its maximum angle relative to the ecliptic. Every 18.6 years, the tilts combine to cause the moon to rise and set as much as 28.5° north or south of due east and west, respectively.
Most people won't notice the major lunar standstill, but if you regularly watch the full moon rise from a particular place, go there — you'll get a shock when the moon rises at an extreme position much farther from where you might imagine it will rise.
Imaging a full moon using a smartphone isn't easy, but it is possible to capture something special. First, switch off your flash and turn on HDR mode (if available) to better capture both the moon and the landscape as the light fades during dusk. Don't zoom in because digital zoom only blurs the details. Instead, frame the moon within a landscape for more impact, which is especially effective during this month's unusually far-southeast moonrise. If you use a manual photography app, stick to an ISO of 100 for a clean shot and experiment with slower (but not too slow) shutter speeds. A tripod will help, especially when using slow shutter speeds. However, if you don't have one, you can balance your phone on a wall or ledge.
The key is to image it when it's low on the horizon and glowing orange. You've got a short window to capture that color, even with this low-hanging full moon, which will turn bright white as it lifts above the horizon.
Wishing you clear skies and wide eyes.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
13 hours ago
- Medscape
Chemotherapy Linked to Brain Atrophy in Breast
Patients with breast cancer who undergo chemotherapy may face an increased risk for brain atrophy and cognitive decline, new findings from a pilot study suggested. Memory problems in patients with cancer may not stem solely from stress or anxiety related to their diagnosis but could reflect underlying changes in brain structure, study investigator Paul Edison, PhD, MPhil, professor of neuroscience and clinical professor of neurology at Imperial College London, London, England, told Medscape Medical News . While the findings suggest that chemotherapy may contribute to neuronal damage, the researchers noted that many aspects of the relationship between treatment and brain changes remain unclear. Edison highlighted three key areas that require further investigation — uncovering the mechanisms driving brain atrophy, determining the proportion of patients affected, and identifying effective prevention strategies. Another investigator on the study, Laura Kenny, MD, PhD, associate professor and consultant medical oncologist at Imperial College London, noted that the issue has received limited attention to date but expressed hope that the findings will raise awareness and encourage further research, given its clinical importance. The findings were presented on July 29 at the Alzheimer's Association International Conference (AAIC) 2025. Investigating Cognitive Impact Advances in chemotherapeutic agents have improved survival rates in patients with cancer. However, challenges persist regarding the long-term impact of these drugs. Chemotherapy-associated cognitive impairment, often referred to as 'brain fog' or 'chemobrain,' affects approximately one third of patients with breast cancer following treatment. While cognitive decline resolves within 12 months for some patients, others experience persistent effects that may elevate the risk for neurodegenerative conditions, Edison explained. To evaluate the impact of chemotherapy on the brain, investigators studied 328 women with nonmetastatic breast cancer who had undergone chemotherapy within the past 12 months. Patients received either anthracycline — a drug derived from the Streptomyces peucetius bacterium — or taxanes such as docetaxel and paclitaxel, both commonly used in breast cancer treatment, or a combination of these agents. In addition, some patients may also have had hormone therapy at some point during treatment, said Kenny. Participants completed neurocognitive prescreening tests every 3 months using a specialized artificial intelligence-driven platform, allowing them to take detailed memory assessments online from home. Among those prescreened, 18 individuals with lower neurocognitive scores (mean age, approximately 55 years) and 19 cognitively normal control individuals without breast cancer (mean age, approximately 67 years) underwent comprehensive, in-person, neurocognitive evaluations and MRI scans. Researchers analyzed the scans using region of interest (ROI) and voxel-based morphometry (VBM), which uses sophisticated computer software, to assess grey matter volumes and surface areas. The ROI analysis revealed significant reductions in gray matter volume (measured in mm3) and surface area (measured in mm2) among patients experiencing chemobrain, particularly affecting the isthmus cingulate and pars opercularis, with changes extending into the orbitofrontal and temporal regions. Significant Atrophy The VBM analysis confirmed significant atrophy in the frontal, parietal, and cingulate regions of patients with chemobrain compared with control individuals ( P < .05). Edison noted that this pattern overlaps with brain changes typically observed in Alzheimer's disease and vascular cognitive impairment. For both analyses, 'we demonstrated there is some amount of shrinkage in the brain among patients with chemobrain.' he said. 'The fact that controls are older means the results are even more significant as there's more brain atrophy as people age.' Some of the affected brain regions may be linked to impaired memory, a hallmark of Alzheimer's disease, but Edison cautioned that given the small sample size this finding should be interpreted with caution. While the analysis demonstrated overall lower brain volumes in patients with 'chemobrain' compared with controls, Edison emphasized that this finding reflects a single time point and does not indicate brain shrinkage over time. Other events, including stroke — can also cause brain changes. Edison highlighted the importance of determining the significance of these brain changes, how they affect patients and whether they can be prevented. In-person neurocognitive testing revealed significantly reduced semantic and verbal fluency, as well as lower Mini-Mental State Examination scores in patients with chemobrain. Edison noted that these results support the MRI findings. The team plans to follow patients to track brain changes and memory recovery, Kenny said. While patients with breast cancer are a common focus, the researchers intend to expand the study to other cancers in both men and women, said Kenny. Anecdotally, many patients report memory problems during chemotherapy, she added. Based on discussions with her oncology colleagues, Kenny noted that many patients anecdotally report experiencing memory problems during chemotherapy. More Research Needed Commenting for Medscape Medical News , Rebecca M. Edelmayer, PhD, vice president, Scientific Engagement, at the Alzheimer's Association, said the research may help shed light on why women are more likely to develop dementia than men. For years now, experts have been trying to figure out what puts women at higher risk for AD and other dementias, said Edelmayer. 'We still don't understand whether this involves biologically driven risk factors or socially driven risk factors.' Research linking treatments for other health conditions to increased memory problems may offer some clues, she noted, suggesting a potential avenue for further investigation into the intersection of chemotherapy and neurodegenerative diseases such as Alzheimer's. However, Edelmayer emphasized that this line of research is still in its infancy. Much more work is needed to determine whether there is a direct cause-and-effect relationship with specific chemotherapy drugs, and whether some patients may already be predisposed or at higher risk for cognitive decline, she said. Also commenting for Medscape Medical News , Eric Brown, MD, associate scientist and associate chief of geriatric psychiatry at the Centre for Addiction and Mental Health in Toronto, Ontario, Canada, raised concerns about the study's design. One issue, he noted, is that the researchers did not image all patients who received chemotherapy but instead selected those with the most significant cognitive impairment. As a result, the findings may not have reflected outcomes in the average post-chemotherapy patients but rather represent the most severely affected subgroup. Brown also pointed out that the study did not clarify whether this subgroup had comorbid conditions. It's possible, he said, that some individuals may have had Alzheimer's disease or other forms of dementia unrelated to chemotherapy. He agreed that tracking longitudinal changes in both cognitive scores and neuroimaging — comparing patients who receive chemotherapy with those who do not — would be a valuable next step.
Yahoo
13 hours ago
- Yahoo
Scientists issue warning after discovering dangerous particles blowing in wind: 'The impacts on human health are concerning'
Scientists issue warning after discovering dangerous particles blowing in wind: 'The impacts on human health are concerning' Sewage overflows and coastal winds could be sending "billions" of microplastics into the air, according to a study. While research is still in its early stages, scientists worry about the health impacts of this airborne plastic pollution. What's happening? The Plymouth Marine Laboratory study, published in the journal Scientific Reports, analyzed two years of data on sewer overflows and wind conditions in Plymouth Sound, off the coast of England, to determine when conditions were conducive to "aerosolization" — the transfer of microplastics into the air. Out of those two years, 178 days had conditions that could have resulted in microplastics and nanoplastics (MNPs) being carried from the sea to the air. Once in the air, the MNPs could have been inhaled by humans, the scientists hypothesized. The group of experts from the University of Plymouth and the Plymouth Marine Laboratory conducted the study to test whether these conditions could be a significant source of air pollution. Why is microplastic pollution concerning? Experts have long raised concerns about the adverse effects of microplastics on human health. The team that conducted this study has called for more research into the link between sewage overspill and airborne plastic pollution. The authors may have determined why the microplastics that are believed to enter oceans and the real-time data didn't align. David Moffat, artificial intelligence and data scientist lead at Plymouth Marine Laboratory and co-author of the study, emphasized that "the impacts on human health are concerning." A second co-author, Clive Sabel, professor of big data and spatial science at the University of Plymouth, said, "Inhaled microplastics can cross into our blood streams and … accumulate in organs such as our brains and livers." Other experts have found that microplastics could pose a significant risk to human health, from when we breathe them in to where they go once they enter the body. While research is limited, a study published in the journal Environmental Research linked microplastics in the body to respiratory disorders, fatigue, dizziness, and gastrointestinal concerns. Do you worry about air pollution in your town? All the time Often Only sometimes Never Click your choice to see results and speak your mind. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet. Solve the daily Crossword
Yahoo
17 hours ago
- Yahoo
Miniature Neutrino Detector Catches Elusive Particles at Nuclear Reactor
A relatively small detector caught neutrinos from a nuclear reactor using a technique known as coherent scattering Physicists have caught neutrinos from a nuclear reactor using a device weighing just a few kilograms, orders of magnitude less massive than standard neutrino detectors. The technique opens new ways to stress-test the known laws of physics and to detect the copious neutrinos produced in the hearts of collapsing stars. 'They finally did it,' says Kate Scholberg, a physicist at Duke University in Durham, North Carolina. 'And they have very beautiful result.' The experiment, called CONUS+, is described on 30 July in Nature. Challenging quarry Neutrinos are elementary particles that have no electrical charge and generally don't interact with other matter, making them extraordinarily difficult to detect. Most neutrino experiments catch these elusive particles by observing flashes of light that are generated when a neutrino collides with an electron, proton or neutron. These collisions occur extremely infrequently, so such detectors typically have masses of tonnes or thousands of tonnes to provide enough target material to gather neutrinos in relevant numbers. [Sign up for Today in Science, a free daily newsletter] Scholberg and her collaborators first demonstrated the mini-detector technique in 2017, using it to catch neutrinos produced by an accelerator at Oak Ridge National Laboratory in Tennessee. The Oak Ridge particles have slightly higher energies than those made in reactors. As a result, detecting reactor neutrinos was even more challenging, she says. But lower-energy neutrinos also allow for a more precise test of the standard model of physics. Scholberg's COHERENT detector was the first to exploit a phenomenon called coherent scattering, in which a neutrino 'scatters' off an entire atomic nucleus rather than the atom's constituent particles. Coherent scattering uses the fact that particles of matter can act as waves — and the lower the particles' energy, the longer their wavelength, says Christian Buck, a leader of the CONUS collaboration. If the wavelength of a neutrino is similar to the nucleus's diameter, 'then the neutrino sees the nucleus as one thing. It doesn't see the internal structure', says Buck, who is a physicist at the Max Planck Institute for Nuclear Physics in Heidelberg, Germany. The neutrino doesn't interact with any subatomic particles, but does cause the nucleus to recoil — depositing a tiny amount of energy into the detector. Catching sight of a nucleus Coherent scattering occurs more than 100 times as frequently as the interactions used in other detectors, where the neutrino 'sees' a nucleus as a collection of smaller particles with empty space in between. This higher efficiency means that detectors can be smaller and still spot a similar number of particles in the same time frame. 'Now you can afford to build detectors on the kilogram scale,' Buck says. The downside is that the neutrinos deposit much less energy at the nucleus. The recoil induced on a nucleus by a neutrino is comparable to that produced on a ship by a ping-pong ball, Buck says — and has until recent years has been extremely challenging to measure. The CONUS detector is made of four modules of pure germanium, each weighing 1 kilogram. It operated at a nuclear reactor in Germany from 2018 until that reactor was shut down in 2022. The team then moved the detector, upgraded to CONUS+, to the Leibstadt nuclear power plant in Switzerland. From the new location, the team now reports having seen around 395 collision events in 119 days of operation — consistent with the predictions of the standard model of particle physics. After COHERENT's landmark 2017 result, which was obtained with detectors made of caesium iodide, Scholberg's team repeated the feat with detectors made of argon and of germanium. Separately, last year, two experiments originally designed to hunt for dark matter reported seeing hints of low-energy coherent scattering of neutrinos produced by the Sun. Scholberg says that the standard model makes very clean predictions of the rate of coherent scattering and how it changes with different types of atomic nucleus, making it crucial to compare results from as many detecting materials as possible. And if the technique's sensitivity improves further, coherent scattering could help to push forward the state of the art of solar science. Researchers say that coherent scattering will probably not completely replace any existing technologies for detecting neutrinos. But it can spot all three known types of neutrino (and their corresponding antiparticles) down to low energies, whereas some other techniques can capture only one type. This ability means it could complement massive detectors that aim to pick up neutrinos at higher energies, such as the Hyper-Kamiokande observatory now under construction in Japan. This article is reproduced with permission and was first published on July 30 2025. Solve the daily Crossword
